These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16261676)

  • 21. Effects of aldose reductase inhibitor and vitamin B12 on myocardial uptake of iodine-123 metaiodobenzylguanidine in patients with non-insulin-dependent diabetes mellitus.
    Utsunomiya K; Narabayashi I; Tamura K; Nakatani Y; Saika Y; Onishi S; Kariyone S
    Eur J Nucl Med; 1998 Dec; 25(12):1643-8. PubMed ID: 9871096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyol pathway activity in nervous tissues of diabetic and galactose-fed rats: effect of dietary galactose withdrawal or tolrestat intervention therapy.
    Sredy J; Sawicki DR; Notvest RR
    J Diabet Complications; 1991; 5(1):42-7. PubMed ID: 1830318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Washout of I-123 meta-iodobenzylguanidine for assessing cardiac sympathetic activity with progression of hypertension in Dahl salt-sensitive rats.
    Takatsu H; Noda T; Arai M; Kunishima A; Inoue M; Tazawa S; Kurosawa H; Nishigaki K; Fujiwara H
    J Nucl Cardiol; 1999; 6(2):204-10. PubMed ID: 10327105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H; Tawata M; Aida K; Onaya T
    J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormalities of cardiac sympathetic function in pacing-induced heart failure as assessed by [123I]metaiodobenzylguanidine scintigraphy.
    Simmons WW; Freeman MR; Grima EA; Hsia TW; Armstrong PW
    Circulation; 1994 Jun; 89(6):2843-51. PubMed ID: 8205700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dependence of cardiac 11C-meta-hydroxyephedrine retention on norepinephrine transporter density.
    Raffel DM; Chen W; Sherman PS; Gildersleeve DL; Jung YW
    J Nucl Med; 2006 Sep; 47(9):1490-6. PubMed ID: 16954558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Basso M; Hohman TC
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scintigraphic imaging with 123I-metaiodobenzylguanidine as a marker of cardiac adrenergic neurotransmission in the rat.
    Gayheart-Walsten P; Snyder D; Mack J; Boland C; Roberts J
    Methods Find Exp Clin Pharmacol; 1995 May; 17(4):249-54. PubMed ID: 7475511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Technetium-99m labeled 1-(4-fluorobenzyl)-4-(2-mercapto-2-methyl-4-azapentyl)-4-(2-mercapto-2-methylpropylamino)-piperidine and iodine-123 metaiodobenzylguanidine for studying cardiac adrenergic function: a comparison of the uptake characteristics in vascular smooth muscle cells and neonatal cardiac myocytes, and an investigation in rats.
    Samnick S; Scheuer C; Münks S; El-Gibaly AM; Menger MD; Kirsch CM
    Nucl Med Biol; 2004 May; 31(4):511-22. PubMed ID: 15093822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of regional cardiac sympathetic innervation in congenital long QT syndrome using 123I-MIBG scintigraphy.
    Momose M; Kobayashi H; Kasanuki H; Kusakabe K; Tamaki A; Onishi S; Okawa T
    Nucl Med Commun; 1998 Oct; 19(10):943-51. PubMed ID: 10234674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The heterogeneity of myocardial sympathetic innervation in normal subjects: an assessment by iodine-123 metaiodobenzylguanidine scintigraphy].
    D'Alto M; Maurea S; Basso A; Varrella P; Polverino W; Bianchi U; Bonelli A; Salvatore M; Chiariello M
    Cardiologia; 1998 Nov; 43(11):1231-6. PubMed ID: 9922590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
    Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
    Metabolism; 1979 Apr; 28(4 Suppl 1):456-61. PubMed ID: 122297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new norepinephrine transporter imaging agent for cardiac sympathetic nervous function imaging: radioiodinated (R)-N-methyl-3-(2-iodophenoxy)-3-phenylpropanamine.
    Kiyono Y; Kanegawa N; Kawashima H; Fujiwara H; Iida Y; Nishimura H; Saji H
    Nucl Med Biol; 2003 Oct; 30(7):697-706. PubMed ID: 14499327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of sorbitol pathway and treatment effect of aldose reductase inhibitor ONO2235 in the up-regulation of cardiac M2-muscarinic receptors in streptozotocin-induced diabetic rats.
    Liu TP; Juang SW; Cheng JT; Tong YC
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):131-5. PubMed ID: 15936525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy.
    Terai H; Shimizu M; Ino H; Yamaguchi M; Uchiyama K; Oe K; Nakajima K; Taki J; Kawano M; Mabuchi H
    J Nucl Med; 2003 Oct; 44(10):1612-7. PubMed ID: 14530475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation.
    De Marco T; Dae M; Yuen-Green MS; Kumar S; Sudhir K; Keith F; Amidon TM; Rifkin C; Klinski C; Lau D
    J Am Coll Cardiol; 1995 Mar; 25(4):927-31. PubMed ID: 7884099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac sympathetic dysinnervation in Type 2 diabetes mellitus with and without ECG-based cardiac autonomic neuropathy.
    Schnell O; Hammer K; Muhr-Becker D; Ziegler A; Weiss M; Tatsch K; Standl E
    J Diabetes Complications; 2002; 16(3):220-7. PubMed ID: 12015192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. meta-iodobenzylguanidine uptake in the hypertensive-diabetic rat heart: a marker for myocardial dysfunction?
    Herman LM; Dai S; Hartman NG; McNeill JH
    Can J Physiol Pharmacol; 1994 Oct; 72(10):1162-7. PubMed ID: 7882180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of [123I]metaiodobenzylguanidine kinetics with heart rate variability and plasma norepinephrine level.
    Kurata C; Shouda S; Mikami T; Wakabayashi Y; Nakano T; Sugiyama T; Tawarahara K; Sakata K
    J Nucl Cardiol; 1997; 4(6):515-23. PubMed ID: 9456192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-body evaluation of MIBG tissue extraction in a mouse model of long-lasting type II diabetes and its relationship with norepinephrine transport protein concentration.
    Kusmic C; Morbelli S; Marini C; Matteucci M; Cappellini C; Pomposelli E; Marzullo P; L'abbate A; Sambuceti G
    J Nucl Med; 2008 Oct; 49(10):1701-6. PubMed ID: 18794257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.